Dalia Dickman, PhD

VP Clinical & Regulatory Affairs

Dr. Dickman has over 20 years of successful experience leading product commercialization of innovative medical devices from inception to sales with expertise in clinical and regulatory affairs as well as product management.

Over the years, Dr. Dickman has held various management positions in all areas of the product life cycle with a forte in leading clinical development and regulatory strategy resulting in clearance for marketing globally. Dr. Dickman holds a MSc in Medical Science and a PhD in Molecular Biology from the Technion Institute of Technology in Israel. She is author and co-author of numerous publications and patents with expertise in medical imaging and diagnostics.


Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved